Trial Profile
Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2013
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Biomarker; Pharmacodynamics
- 10 Mar 2013 New trial record